Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 1
Lung Cancer: Targets and Therapy
ISSN: 1179-2728
- View all (171)
- Volume 14, 2023 (11)
- Volume 13, 2022 (8)
- Volume 12, 2021 (14)
- Volume 11, 2020 (11)
- Volume 10, 2019 (16)
- Volume 9, 2018 (14)
- Volume 8, 2017 (25)
- Volume 7, 2016 (17)
- Volume 6, 2015 (9)
- Volume 5, 2014 (10)
- Volume 4, 2013 (9)
- Volume 3, 2012 (9)
- Volume 2, 2011 (6)
- Volume 1, 2010 (12)
Archive: Volume 1, 2010
Dyspnea in lung cancer patients: a systematic review
Ganesan Kathiresan, Reynold F Clement, Meera T Sankaranarayanan
Lung Cancer: Targets and Therapy 2010, 1:141-150
Published Date: 23 November 2010
Azacitidine and decitabine have different mechanisms of action in non-small cell lung cancer cell lines
Aaron N Nguyen, Paul W Hollenbach, Normand Richard, et al
Lung Cancer: Targets and Therapy 2010, 1:119-140
Published Date: 10 September 2010
Genome-wide gene expression analysis of chemoresistant pulmonary carcinoid cells
Ulrike Olszewski, Robert Zeillinger, Klaus Geissler, et al
Lung Cancer: Targets and Therapy 2010, 1:107-117
Published Date: 6 September 2010
The role of maintenance pemetrexed in the treatment of non-small-cell lung cancer
Saeed Rafii, Michael H Cullen
Lung Cancer: Targets and Therapy 2010, 1:101-106
Published Date: 30 July 2010
Astragalus-containing Chinese herbal combinations for advanced non-small-cell lung cancer: a meta-analysis of 65 clinical trials enrolling 4751 patients
Jean Jacques Dugoua, Ping Wu, Dugald Seely, et al
Lung Cancer: Targets and Therapy 2010, 1:85-100
Published Date: 9 July 2010
Circulating tumor cells (CTCs) in lung cancer: current status and future perspectives
Fumihiro Tanaka, Kazue Yoneda, Seiki Hasegawa
Lung Cancer: Targets and Therapy 2010, 1:77-84
Published Date: 7 July 2010
Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysis
Matthew A Gubens, Heather A Wakelee
Lung Cancer: Targets and Therapy 2010, 1:63-76
Published Date: 16 June 2010
Shifting the paradigm for maintenance therapy in advanced non-small-cell lung cancer
Barbara Melosky
Lung Cancer: Targets and Therapy 2010, 1:53-62
Published Date: 9 June 2010
Standing the test of time in Europe? Gefitinib in the treatment of non-small-cell lung cancer
Caroline Wilson, Sarah J Danson
Lung Cancer: Targets and Therapy 2010, 1:37-51
Published Date: 13 May 2010
Drug resistance in lung cancer
Manish Shanker, David Willcutts, Jack A Roth, et al
Lung Cancer: Targets and Therapy 2010, 1:23-36
Published Date: 13 May 2010
Refining the treatment of advanced nonsmall cell lung cancer
Shin Ogita, Antoinette J Wozniak
Lung Cancer: Targets and Therapy 2010, 1:9-22
Published Date: 4 May 2010
Maintenance therapy for metastatic non-small-cell lung cancer – the role of pemetrexed
Youval Katz, Robert A Somer
Lung Cancer: Targets and Therapy 2010, 1:1-7
Published Date: 12 April 2010